Lindh JD - Search Results

1

Impact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysis.

Chang M, Tybring G, Dahl ML, Lindh JD. Chang M, et al. Among authors: lindh jd. Clin Pharmacokinet. 2014 Sep;53(9):801-11. doi: 10.1007/s40262-014-0162-1. Clin Pharmacokinet. 2014. PMID: 25154506 Review.

2

Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.

Lindh JD, Annas A, Meurling L, Dahl ML, AL-Shurbaji A. Lindh JD, et al. Eur J Clin Pharmacol. 2003 Sep;59(5-6):401-6. doi: 10.1007/s00228-003-0627-x. Epub 2003 Jul 25. Eur J Clin Pharmacol. 2003. PMID: 12898080 Clinical Trial.

3

Incidence and predictors of severe bleeding during warfarin treatment.

Lindh JD, Holm L, Dahl ML, Alfredsson L, Rane A. Lindh JD, et al. J Thromb Thrombolysis. 2008 Apr;25(2):151-9. doi: 10.1007/s11239-007-0048-2. Epub 2007 May 20. J Thromb Thrombolysis. 2008. PMID: 17514429

4

Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome.

Panagiotidis G, Arthur HW, Lindh JD, Dahl ML, Sjöqvist F. Panagiotidis G, et al. Among authors: lindh jd. Ther Drug Monit. 2007 Aug;29(4):417-22. doi: 10.1097/FTD.0b013e31811f394d. Ther Drug Monit. 2007. PMID: 17667795

5

Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis.

Lindh JD, Holm L, Andersson ML, Rane A. Lindh JD, et al. Eur J Clin Pharmacol. 2009 Apr;65(4):365-75. doi: 10.1007/s00228-008-0584-5. Epub 2008 Nov 25. Eur J Clin Pharmacol. 2009. PMID: 19031075 Review.

6

A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and age.

Hamberg AK, Wadelius M, Lindh JD, Dahl ML, Padrini R, Deloukas P, Rane A, Jonsson EN. Hamberg AK, et al. Among authors: lindh jd. Clin Pharmacol Ther. 2010 Jun;87(6):727-34. doi: 10.1038/clpt.2010.37. Epub 2010 Apr 21. Clin Pharmacol Ther. 2010. PMID: 20410877

7

CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients.

Margolin S, Lindh JD, Thorén L, Xie H, Koukel L, Dahl ML, Eliasson E. Margolin S, et al. Among authors: lindh jd. Pharmacogenomics. 2013 Apr;14(6):613-22. doi: 10.2217/pgs.13.47. Pharmacogenomics. 2013. PMID: 23570465

8

Therapeutic drug monitoring for tomorrow.

Eliasson E, Lindh JD, Malmström RE, Beck O, Dahl ML. Eliasson E, et al. Among authors: lindh jd. Eur J Clin Pharmacol. 2013 May;69 Suppl 1:25-32. doi: 10.1007/s00228-013-1504-x. Epub 2013 May 3. Eur J Clin Pharmacol. 2013. PMID: 23640185 Review.

9

Plasma levels of 25-hydroxyvitamin D3 and in vivo markers of cytochrome P450 3A activity in Swedes and Koreans: effects of a genetic polymorphism and oral contraceptives.

Nylén H, Björkhem-Bergman L, Ekström L, Roh HK, Bertilsson L, Eliasson E, Lindh JD, Diczfalusy U. Nylén H, et al. Among authors: lindh jd. Basic Clin Pharmacol Toxicol. 2014 Oct;115(4):366-71. doi: 10.1111/bcpt.12230. Epub 2014 Apr 11. Basic Clin Pharmacol Toxicol. 2014. PMID: 24655660 Free article.

10

Quantitative methods for prediction of the effect of cytochrome P450 gene polymorphisms on substrate drug exposure: authors' reply.

Lindh JD, Chang M, Tybring G, Dahl ML. Lindh JD, et al. Clin Pharmacokinet. 2015 Mar;54(3):321. doi: 10.1007/s40262-014-0220-8. Clin Pharmacokinet. 2015. PMID: 25488593 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page